Andrew C. Adams

10.5k total citations · 3 hit papers
56 papers, 5.7k citations indexed

About

Andrew C. Adams is a scholar working on Molecular Biology, Physiology and Endocrine and Autonomic Systems. According to data from OpenAlex, Andrew C. Adams has authored 56 papers receiving a total of 5.7k indexed citations (citations by other indexed papers that have themselves been cited), including 45 papers in Molecular Biology, 10 papers in Physiology and 8 papers in Endocrine and Autonomic Systems. Recurrent topics in Andrew C. Adams's work include Fibroblast Growth Factor Research (42 papers), Epigenetics and DNA Methylation (32 papers) and Kruppel-like factors research (27 papers). Andrew C. Adams is often cited by papers focused on Fibroblast Growth Factor Research (42 papers), Epigenetics and DNA Methylation (32 papers) and Kruppel-like factors research (27 papers). Andrew C. Adams collaborates with scholars based in United States, United Kingdom and Netherlands. Andrew C. Adams's co-authors include Alexei Kharitonenkov, Eleftheria Maratos–Flier, Christine C. Cheng, Shuichi Koda, Bradford B. Lowell, Michael J. Krashes, Bryan L. Roth, Sarah C. Rogan, Tamer Coşkun and Matthew M. Hufford and has published in prestigious journals such as Journal of Biological Chemistry, Journal of Clinical Investigation and Nature reviews. Immunology.

In The Last Decade

Andrew C. Adams

56 papers receiving 5.6k citations

Hit Papers

align trajectories

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

Rapid, reversible activation of AgRP neurons drives feeding behavior in mice

2011 1.1k citations Michael J. Krashes, Shuichi Koda et al. Journal of Clinical Investigation profile →
An FGF21-Adiponectin-Ceramide Axis Controls Energy Expenditure and Insulin Action in Mice

2013 455 citations William L. Holland, Andrew C. Adams et al. Cell Metabolism profile →
Neutralizing monoclonal antibodies for treatment of COVID-19

2021 453 citations Andrew C. Adams et al. profile →

Peers

Countries citing papers authored by Andrew C. Adams

Since Specialization

Citations

This map shows the geographic impact of Andrew C. Adams's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Andrew C. Adams with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Andrew C. Adams more than expected).

Fields of papers citing papers by Andrew C. Adams

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Andrew C. Adams. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Andrew C. Adams. The network helps show where Andrew C. Adams may publish in the future.

Co-authorship network of co-authors of Andrew C. Adams

This figure shows the co-authorship network connecting the top 25 collaborators of Andrew C. Adams. A scholar is included among the top collaborators of Andrew C. Adams based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Andrew C. Adams. Andrew C. Adams is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

#	Work	Indexed citations
1	Targeting hepatic serine-arginine protein kinase 2 ameliorates alcohol-associated liver disease by alternative splicing control of lipogenesis 2023 ·Hepatology ·Guannan Li, Han-Qing Chen, Feng Shen, (unknown), (unknown), (unknown), Zerong Liang, Jingyan Han, Andrew C. Adams, Yu Li, Dechun Feng, Bin Gao, Masahiro Morita, Xianlin Han, Tim Huang, Nicolas Musi, Mengwei Zang	12
2	Discovery, development, and clinical proof of mechanism of LY3463251, a long-acting GDF15 receptor agonist 2023 ·Cell Metabolism ·Olivier Bénichou, Tamer Coşkun, Malgorzata D. Gonciarz, Parag Garhyan, Andrew C. Adams, Yu Du, James D. Dunbar, Jennifer A. Martin, Kieren J. Mather, Richard T. Pickard, Vincent L. Reynolds, Deborah A. Robins, (unknown), Paul J. Emmerson	52
3	Whole-body and adipose tissue-specific mechanisms underlying the metabolic effects of fibroblast growth factor 21 in the Siberian hamster 2019 ·Molecular Metabolism ·Jo E. Lewis, (unknown), (unknown), Maxine J Fowler, (unknown), Scott Cooper, Aristeidis Chiotellis, Jeni Luckett, Alan C. Perkins, Tamer Coşkun, Andrew C. Adams, Ricardo J. Samms, Francis J. P. Ebling, Kostas Tsintzas	18
4	Adipose tissue contribution to plasma fibroblast growth factor 21 and fibroblast activation protein in obesity 2019 ·International Journal of Obesity ·Marleen A. van Baak, Roel Vink, Nadia Roumans, Christine C. Cheng, Andrew C. Adams, Edwin C.M. Mariman	10
5	Cholic Acid Supplementation of a High-Fat Obesogenic Diet Suppresses Hepatic Triacylglycerol Accumulation in Mice via a Fibroblast Growth Factor 21–Dependent Mechanism 2018 ·Journal of Nutrition ·(unknown), Alexei Kharitonenkov, Andrew C. Adams, F. Bradley Hillgartner	18
6	Reduced adiposity attenuates FGF21 mediated metabolic improvements in the Siberian hamster 2017 ·Scientific Reports ·Jo E. Lewis, Ricardo J. Samms, Scott Cooper, Jeni Luckett, Alan C. Perkins, Andrew C. Adams, Kostas Tsintzas, Francis J. P. Ebling	9
7	Acute loss of adipose tissue-derived adiponectin triggers immediate metabolic deterioration in mice 2017 ·Diabetologia ·Jonathan Y. Xia, Kai Sun, Chelsea Hepler, Alexandra L. Ghaben, Rana K. Gupta, Yu An, William L. Holland, Thomas S. Morley, Andrew C. Adams, Ruth Gordillo, Christine M. Kusminski, Philipp E. Scherer	40
8	CMPF, a Metabolite Formed Upon Prescription Omega-3-Acid Ethyl Ester Supplementation, Prevents and Reverses Steatosis 2017 ·EBioMedicine ·Kacey J. Prentice, Stacy G. Wendell, Ying Liu, (unknown), Sonia R. Salvatore, Haneesha Mohan, (unknown), Andrew C. Adams, (unknown), David Wei, Garret A. FitzGerald, Timothy B. Durham, (unknown), Kyle W. Sloop, Carsten Skarke, Francisco J. Schöpfer, Michael B. Wheeler	38
9	Fibroblast Growth Factor 21-Null Mice Do Not Exhibit an Impaired Response to Fasting 2016 ·Frontiers in Endocrinology ·Patrick J. Antonellis, (unknown), Andrew C. Adams	14
10	Discrete Aspects of FGF21 In Vivo Pharmacology Do Not Require UCP1 2015 ·Cell Reports ·Ricardo J. Samms, Dennis P. Smith, Christine C. Cheng, (unknown), James W. Perfield, Alexei Kharitonenkov, Ruth E. Gimeno, Andrew C. Adams	129
11	Dual effects of fibroblast growth factor 21 on hepatic energy metabolism 2015 ·Journal of Endocrinology ·Ricardo J. Samms, Michelle Murphy, Maxine J Fowler, Scott Cooper, (unknown), Tamer Coşkun, Andrew C. Adams, Alexei Kharitonenkov, Francis J. P. Ebling, Kostas Tsintzas	15
12	Antibody-Mediated Inhibition of the FGFR1c Isoform Induces a Catabolic Lean State in Siberian Hamsters 2015 ·Current Biology ·Ricardo J. Samms, Jo E. Lewis, (unknown), Maxine J Fowler, Scott Cooper, Amy Warner, (unknown), Andrew C. Adams, Jeni Luckett, Alan C. Perkins, Dana Wilson, Perry Barrett, Kostas Tsintzas, Francis J. P. Ebling	30
13	Serum FGF21 levels are associated with brown adipose tissue activity in humans 2015 ·Scientific Reports ·Mark J. W. Hanssen, Evie P. M. Broeders, Ricardo J. Samms, Maarten J. Vosselman, Anouk A.J.J. van der Lans, Christine C. Cheng, Andrew C. Adams, Wouter D. van Marken Lichtenbelt, Patrick Schrauwen	113
14	Hepatic SIRT1 Attenuates Hepatic Steatosis and Controls Energy Balance in Mice by Inducing Fibroblast Growth Factor 21 2014 ·DSpace@MIT (Massachusetts Institute of Technology) ·Yu Li, Kimberly Wong, Amber Giles, Jianwei Jiang, Jong Woo Lee, Andrew C. Adams, Alexei Kharitonenkov, Qin Yang, Bin Gao, Mengwei Zang, Leonard Guarente	1
15	Fibroblast Growth Factor 21 Is Not Required for the Reductions in Circulating Insulin-Like Growth Factor-1 or Global Cell Proliferation Rates in Response to Moderate Calorie Restriction in Adult Mice 2014 ·PLoS ONE ·(unknown), Matthew D. Bruss, (unknown), Alexei Kharitonenkov, Andrew C. Adams, Marc K. Hellerstein	12
16	Fibroblast growth factor 21 is not required for the antidiabetic actions of the thiazoladinediones 2013 ·Molecular Metabolism ·Andrew C. Adams, Tamer Coşkun, Christine C. Cheng, Libbey S. O′Farrell, Susan L. DuBois, Alexei Kharitonenkov	68
17	A metabolic prosurvival role for PML in breast cancer 2012 ·Journal of Clinical Investigation ·Arkaitz Carracedo, Dror Weiss, (unknown), Manoj Bhasin, Vincent C. J. de Boer, Gaëlle Laurent, Andrew C. Adams, Maria Sundvall, Su Jung Song, Keisuke Ito, Lydia W.S. Finley, Ainara Egia, Towia A. Libermann, Zachary Gerhart‐Hines, Pere Puigserver, Marcia C. Haigis, (unknown), Andrea L. Richardson, Zachary T. Schafer, Pier Paolo Pandolfi	211
18	FGF21 Requires βklotho to Act In Vivo 2012 ·PLoS ONE ·Andrew C. Adams, Christine C. Cheng, Tamer Coşkun, Alexei Kharitonenkov	154
19	Rapid, reversible activation of AgRP neurons drives feeding behavior in mice breakdown → 2011 ·Journal of Clinical Investigation ·Michael J. Krashes, Shuichi Koda, (unknown), Sarah C. Rogan, Andrew C. Adams, (unknown), Eleftheria Maratos–Flier, Bryan L. Roth, Bradford B. Lowell	1130
20	Chronic Central Administration of Apelin‐13 Over 10 Days Increases Food Intake, Body Weight, Locomotor Activity and Body Temperature in C57BL/6 Mice 2007 ·Journal of Neuroendocrinology ·Adamo Valle, Nigel Hoggard, Andrew C. Adams, Pilar Roca, John R. Speakman	85

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact